The NCCN (National Comprehensive Cancer Network) educational webinar, titled “Optimizing Patient Outcomes – Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations,” is scheduled for May 28, 2026 from 1:00 PM to 2:00 PM EDT.

This program addresses the rapidly evolving systemic therapy landscape of hepatocellular carcinoma (HCC), specifically focusing on recent efficacy data regarding immunotherapy. The session provides a nuanced approach to individualizing treatment for patients with advanced stages of liver dysfunction, helping clinicians decide between systemic therapy and best supportive care.

Designed for a multidisciplinary audience of physicians, nurses, pharmacists, and physician associates, the activity covers first-line and subsequent-line systemic therapy options.

Registration and course access are available through the official NCCN platform.